Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 59

1.

Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function.

Yao L, Pike SE, Tosato G.

J Leukoc Biol. 2002 Jan;71(1):47-53.

PMID:
11781379
2.

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.

Cheng WF, Hung CF, Chai CY, Hsu KF, He L, Ling M, Wu TC.

J Clin Invest. 2001 Sep;108(5):669-78.

3.

CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.

Basu S, Binder RJ, Ramalingam T, Srivastava PK.

Immunity. 2001 Mar;14(3):303-13.

4.

Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation.

Troyanovsky B, Levchenko T, MÃ¥nsson G, Matvijenko O, Holmgren L.

J Cell Biol. 2001 Mar 19;152(6):1247-54.

5.

An interaction between ricin and calreticulin that may have implications for toxin trafficking.

Day PJ, Owens SR, Wesche J, Olsnes S, Roberts LM, Lord JM.

J Biol Chem. 2001 Mar 9;276(10):7202-8. Epub 2000 Dec 11.

6.
7.

Angiogenesis in cancer and other diseases.

Carmeliet P, Jain RK.

Nature. 2000 Sep 14;407(6801):249-57. Review.

PMID:
11001068
8.

Vascular-specific growth factors and blood vessel formation.

Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J.

Nature. 2000 Sep 14;407(6801):242-8. Review.

PMID:
11001067
9.

Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12.

Yao L, Pike SE, Setsuda J, Parekh J, Gupta G, Raffeld M, Jaffe ES, Tosato G.

Blood. 2000 Sep 1;96(5):1900-5.

10.

The conformation of calreticulin is influenced by the endoplasmic reticulum luminal environment.

Corbett EF, Michalak KM, Oikawa K, Johnson S, Campbell ID, Eggleton P, Kay C, Michalak M.

J Biol Chem. 2000 Sep 1;275(35):27177-85.

11.

Mechanisms of angiogenesis and arteriogenesis.

Carmeliet P.

Nat Med. 2000 Apr;6(4):389-95. Review.

PMID:
10742145
12.

Maspin is an angiogenesis inhibitor.

Zhang M, Volpert O, Shi YH, Bouck N.

Nat Med. 2000 Feb;6(2):196-9.

PMID:
10655109
13.

Clinical applications of angiogenic growth factors and their inhibitors.

Ferrara N, Alitalo K.

Nat Med. 1999 Dec;5(12):1359-64. Review.

PMID:
10581076
14.

Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.

Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R.

Nature. 1999 Oct 14;401(6754):670-7.

PMID:
10537105
15.

Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1.

Gohongi T, Fukumura D, Boucher Y, Yun CO, Soff GA, Compton C, Todoroki T, Jain RK.

Nat Med. 1999 Oct;5(10):1203-8.

PMID:
10502827
16.

Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth.

Pike SE, Yao L, Setsuda J, Jones KD, Cherney B, Appella E, Sakaguchi K, Nakhasi H, Atreya CD, Teruya-Feldstein J, Wirth P, Gupta G, Tosato G.

Blood. 1999 Oct 1;94(7):2461-8.

17.

Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis.

Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oosthuyse B, Dewerchin M, Zanetti A, Angellilo A, Mattot V, Nuyens D, Lutgens E, Clotman F, de Ruiter MC, Gittenberger-de Groot A, Poelmann R, Lupu F, Herbert JM, Collen D, Dejana E.

Cell. 1999 Jul 23;98(2):147-57.

18.

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ.

Science. 1999 Jun 18;284(5422):1994-8.

19.

Supplemental Content

Support Center